Classifying Non-Small Cell Lung Cancer by Status of Programmed Cell Death Ligand 1 and Tumor-Infiltrating Lymphocytes on Tumor Cells

por Cui, Shaohua, Dong, Lili, Qian, Jialin, Ye, Lin, Jiang, Liyan
Publicado 2018

Concomitant Mycobacterium tuberculosis infection promotes lung tumor growth through enhancing Treg development

por Zhou, Yan, Hu, Zhangguo, Cao, Shuhui, Yan, Bo, Qian, Jialin, Zhong, Hua
Publicado 2017

Mining GEO and TCGA Database for Immune Microenvironment of Lung Squamous Cell Carcinoma Patients With or Without Chemotherapy

por Qiang, Huiping, Li, Jiaqi, Chang, Qing, Shen, Yinchen, Qian, Jialin, Chu, Tianqing
Publicado 2022

Downregulation of HIF-1α inhibits the proliferation and invasion of non-small cell lung cancer NCI-H157 cells

por QIAN, JIALIN, BAI, HAO, GAO, ZHIQIANG, DONG, YU, PEI, JUN, MA, MEILI, HAN, BAOHUI
Publicado 2016

Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell...

por Li, Jiaqi, Chen, Yingjie, Hu, Fan, Qiang, Huiping, Chang, Qing, Qian, Jialin, Shen, Yinchen, Cai, Yong, Chu, Tianqing
Publicado 2022

Is there a progression‐free survival benefit of first‐line crizotinib versus standard chemotherapy and second‐line crizotinib in ALK‐positive advanced lung adenocarcinoma? A retros...

por Cui, Shaohua, Zhao, Yizhuo, Dong, Lili, Gu, Aiqin, Xiong, Liwen, Qian, Jialin, Zhang, Wei, Niu, Yanjie, Pan, Feng, Jiang, Liyan
Publicado 2016

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients

por Zhang, Yanwei, Sun, Beibei, Hu, Minjuan, Lou, Yuqing, Lu, Jun, Zhang, Xueyan, Wang, Huimin, Qian, Jialin, Chu, Tianqing, Han, Baohui
Publicado 2020

Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective Study

por Chang, Qing, Qiang, Huiping, Qian, Jialin, Lei, Yuqiong, Lu, Jiahuan, Feng, Hui, Zhao, Yiming, Han, Baohui, Zhang, Yanwei, Chu, Tianqing
Publicado 2021

Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells

por Pei, Jun, Chu, Tianqing, Shao, Minhua, Teng, Jiajun, Sha, Huifang, Gu, Aiqing, Li, Rong, Qian, Jialin, Mao, Weifeng, Li, Ying, Han, Baohui
Publicado 2017

Programmed cell death ligand 1 protein levels predicted survival of non-small cell lung cancer

por Cui, Shaohua, Su, Xinying, Dong, Lili, Qian, Jialin, Ye, Lin, Zhang, Tianwei, Fu, Haihua, Han, Hulin, Huang, Jiaqi, Yao, Yihong, Gu, Yi, Jiang, Liyan
Publicado 2017

Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy

por Yu, Xin, Li, Jiaqi, Ye, Lingyun, Zhao, Jing, Xie, Mengqing, Zhou, Juan, Shen, Yinchen, Zhou, Fei, Wu, Yan, Han, Chaonan, Qian, Jialin, Chu, Tianqing, Su, Chunxia
Publicado 2021

A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab

por Shen, Yinchen, Li, Jiaqi, Qiang, Huiping, Lei, Yuqiong, Chang, Qing, Zhong, Runbo, Stella, Giulia Maria, Gelsomino, Francesco, Kim, Yeon Wook, Abed, Afaf, Qian, Jialin, Chu, Tianqing
Publicado 2022

Pembrolizumab monotherapy or combination therapy for bone metastases in advanced non-small cell lung cancer: a real-world retrospective study

por Qiang, Huiping, Lei, Yuqiong, Shen, Yinchen, Li, Jiaqi, Zhong, Hua, Zhong, Runbo, Zhang, Xueyan, Chang, Qing, Lu, Jiahuan, Feng, Hui, Zhu, Yan, Addeo, Alfredo, Banna, Giuseppe L., Oh, In-Jae, Qian, Jialin, Chu, Tianqing
Publicado 2022

Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non‐small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line th...

por Chu, Tianqing, Yuan, Jie, Lu, Jun, Nie, Wei, Zhong, Runbo, Zhang, Bo, Zhang, Wei, Shi, Chunlei, Qian, Jialin, Zhang, Yanwei, Zhang, Xueyan, Teng, Jiajun, Gao, Zhiqiang, Lou, Yuqing, Li, Jiaqi, Qiang, Huiping, Zhang, Chao, Li, Jin, Xia, Xuefeng, Zhong, Hua, Han, Baohui
Publicado 2023

PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC)

por Jiang, Liyan, Su, Xinying, Zhang, Tianwei, Yin, Xiaolu, Zhang, Meizhuo, Fu, Haihua, Han, Hulin, Sun, Yun, Dong, Lili, Qian, Jialin, Xu, Yanhua, Fu, Xuan, Gavine, Paul R., Zhou, Yanbin, Tian, Kun, Huang, Jiaqi, Shen, Dong, Jiang, Haiyi, Yao, Yihong, Han, Baohui, Gu, Yi
Publicado 2017